"Prime demonstrated how actual patients saved on prescription drugs as a result of the agreement [between Prime and Express Scripts, Inc. ('ESI')]. With this ruling, AHF is seeking to rewind the clock ...
An arbitrator has determined Prime Therapeutics violated federal and state antitrust laws against the AIDS Healthcare ...
The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...
The National Community Pharmacists Association has joined a class action lawsuit against GoodRx, as well as CVS Caremark, ...
Newsweek on MSN12d
UnitedHealth Charged Cancer Patients 5000%, Bombshell FTC Report ClaimsThe FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...
The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
The content of the amended complaint from page 53 to page 71 is just concise and direct enough to avoid violating Rule 8,” U.S. District Judge John A. Ross said.
Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback